2023/02/21 17:35:11 | |
---|---|
Price | |
60.00 EUR | |
Difference | 1.52% (0.90) |
ISIN | DE000BAY0017 |
Symbol | BAYN |
Exchange | SIX Swiss Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 29,281 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 60.00 EUR (100) |
Ask (Ask size) | 59.49 EUR (20) |
Open | 60.00 EUR |
High | 60.00 EUR |
Low | 60.00 EUR |
Close (prev. day) | 59.10 EUR |
VWAP | 51.25 EUR |
Volume (pcs) | - |
Trading volume | - |
Number of trades | 1 |
Last size | - |
Related Futures | 53 |
Related Options | - |
Date | Headline | Download | |
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings | ||
2023/12/07 | Global Equity Ratings | ||
2023/11/24 | Global Equity Ratings | ||
2023/10/27 | Global Equity Ratings |
2023/02/21 17:35:11 | |
---|---|
Price | |
60.00 EUR | |
Difference | 1.52% (0.90) |
ISIN | DE000BAY0017 |
Symbol | BAYN |
Exchange | SIX Swiss Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 29,281 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 60.00 EUR (100) |
Ask (Ask size) | 59.49 EUR (20) |
Open | 60.00 EUR |
High | 60.00 EUR |
Low | 60.00 EUR |
Close (prev. day) | 59.10 EUR |
VWAP | 51.25 EUR |
Volume (pcs) | - |
Trading volume | - |
Number of trades | 1 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 1.10 | 1.12 | 0.82 |
Volatility | 81.33 | 78.77 | 36.13 |
Ø price 5 days | Ø volume 5 days (pcs.) | 35.92 EUR (13,947) |
Ø price 30 days | Ø volume 30 days (pcs.) | 22.55 EUR (19,490) |
Ø price 100 days | Ø volume 100 days (pcs.) | 13.68 EUR (35,437) |
Ø price 250 days | Ø volume 250 days (pcs.) | 37.64 EUR (21,911) |
YTD High | date | 60.50 EUR (2023/02/09) |
YTD Low | date | 49.95 EUR (2023/01/04) |
52 Weeks High | date | 60.50 EUR (2023/02/09) |
52 Weeks Low | date | 49.10 EUR (2022/10/07) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/10/07 | 12:24 | 29.34 EUR | 27.39 | 4,995 |
Vienna Stock Exchange | 2024/10/07 | 11:00 | 29.31 EUR | 0.01 | 4 |
Tradegate | 2024/10/07 | 12:24 | 29.345 EUR | 4.22 | 469 |
Stuttgart | 2024/10/07 | 12:20 | 29.32 EUR | 1.47 | 102 |
SIX Swiss Exchange | 2023/02/21 | 17:35 | 60.00 EUR | 0.00 | 1 |
SIX Swiss Exchange | 2024/06/14 | 17:35 | 179.00 CHF | 0.00 | 1 |
Munich | 2024/10/07 | 09:14 | 29.50 EUR | 0.01 | 3 |
London Stock Exchange European Trade Reporting | 2024/10/07 | 09:00 | 29.8025 EUR | 0.00 | 1 |
Hanover | 2024/10/07 | 08:03 | 29.825 EUR | 0.00 | 1 |
Hamburg | 2024/10/07 | 11:36 | 29.23 EUR | 0.01 | 4 |
Frankfurt | 2024/10/07 | 11:57 | 29.29 EUR | 0.05 | 9 |
FINRA other OTC Issues | 2024/10/04 | 18:46 | 32.67 USD | 0.10 | 8 |
Euronext Milan MTF Trading After Hours | 2024/09/25 | 18:29 | 28.90 EUR | 0.01 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/07 | 12:12 | 29.23 EUR | 0.67 | 93 |
Duesseldorf | 2024/10/07 | 09:31 | 28.97 EUR | 0.00 | 3 |
Budapest Stock Exchange | 2024/10/07 | 09:02 | 12,200.00 HUF | 0.24 | 1 |
Bucharest Stock Exchange | 2024/10/07 | 10:28 | 145.70 RON | 0.00 | 2 |
Berlin | 2024/10/07 | 11:44 | 29.275 EUR | 0.00 | 6 |
BAYER AG |
- - |
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen |
Telefon: +49-214-30-1 |
Fax: + |
E-mail: - |
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and womenšs health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany. |
B. Chuck Anderson | Chairman of Managing Board |
Heike Prinz | Member of Executive Committee |
Julio Triana | Member of Executive Committee |
Rodrigo Santos | Member of Executive Committee |
Stefan Oelrich | Member of Executive Committee |
Wolfgang Nickl | Member of Executive Committee |
Norbert Winkeljohann | Chairman of Supervisory Board |
Barbara Gansewendt | Member of Supervisory Board |
Ertharin Cousin | Member of Supervisory Board |
Nancy Simonian | Member of Supervisory Board |
Paul Achleitner | Member of Supervisory Board |
Alberto Weisser | Member of Supervisory Board |
Andrea Sacher | Member of Supervisory Board |
André van Broich | Member of Supervisory Board |
Claudia Schade | Member of Supervisory Board |
Colleen Goggins | Member of Supervisory Board |
Francesco Grioli | Member of Supervisory Board |
Frank Löllgen | Member of Supervisory Board |
Heike Hausfeld | Member of Supervisory Board |
Heinz Georg Webers | Member of Supervisory Board |
Horst Heinz Paul Baier | Member of Supervisory Board |
Jeffrey Ubben | Member of Supervisory Board |
Kimberly Marie Lein-Mathisen | Member of Supervisory Board |
Lori Schechter | Member of Supervisory Board |
Michael Westmeier | Member of Supervisory Board |
Yasmin Fahimi | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.
The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.